Barinthus Biotherapeutics - 53 Year Dividend History | BRNS

Historical dividend payout and yield for Barinthus Biotherapeutics (BRNS) since 1971. The current TTM dividend payout for Barinthus Biotherapeutics (BRNS) as of May 17, 2024 is $0.00. The current dividend yield for Barinthus Biotherapeutics as of May 17, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.095B $0.001B
Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases. The company's product pipeline includes VTP-300, VTP-200, VTP-1000, VTP-850 and VTP-1100. Barinthus Biotherapeutics plc, formerly known as Vaccitech plc, is based in OXFORD, United Kingdom.
Stock Name Country Market Cap PE Ratio